[{"from": "human", "value": "Describe this molecule. [C][C][=C][C][=C][Branch1][Ring2][N][Ring1][Branch1][C][=C][C][=Branch1][Branch1][=C][Ring1][#Branch1][F][O][C][=N][C][=N][N][C][Ring1][=Branch1][=C][Branch2][Ring1][#Branch1][C][=Branch1][Ring2][=C][Ring1][Branch1][O][C][C@@H1][Branch1][C][C][O][C][=Branch1][C][=O][C@H1][Branch1][C][C][N][C]"}, {"from": "gpt", "value": "The molecule is the alaninate salt of a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with potential antineoplastic activity. Brivanib strongly binds to and inhibits VEGFR2, a tyrosine kinase receptor expressed almost exclusively on vascular endothelial cells; inhibition of VEGFR2 may result in inhibition of tumor angiogenesis, inhibition of tumor cell growth, and tumor regression."}]